论文信息 - Linifanib (ABT-869), enhances cytotoxicity with poly (ADP-ribose) polymerase inhibitor, veliparib (ABT-888), in head and neck carcinoma cells. - 字舞流文

Linifanib (ABT-869), enhances cytotoxicity with poly (ADP-ribose) polymerase inhibitor, veliparib (ABT-888), in head and neck carcinoma cells.

R. Ferris | P. Duerksen-Hughes | C. Chen | V. Williams | S. Mirshahidi | A. Simental | R. de Necochea-Campion | Heng-Wei Hsu